Two distinct conformations of helix 6 observed in antagonist-bound structures of a 1-adrenergic receptor
about
Diversity and modularity of G protein-coupled receptor structuresLarge-scale production and protein engineering of G protein-coupled receptors for structural studiesNew insights for drug design from the X-ray crystallographic structures of G-protein-coupled receptorsEndogenous lipid activated G protein-coupled receptors: emerging structural features from crystallography and molecular dynamics simulationsCrystal structure of oligomeric β1-adrenergic G protein–coupled receptors in ligand-free basal stateBiophysical Fragment Screening of the β 1 -Adrenergic Receptor: Identification of High Affinity Arylpiperazine Leads Using Structure-Based Drug DesignCrystal Structures of a Stabilized β1-Adrenoceptor Bound to the Biased Agonists Bucindolol and CarvedilolThe 2.1 Å Resolution Structure of Cyanopindolol-Bound β1-Adrenoceptor Identifies an Intramembrane Na+ Ion that Stabilises the Ligand-Free ReceptorSmall molecules with similar structures exhibit agonist, neutral antagonist or inverse agonist activity toward angiotensin II type 1 receptor3D structure prediction of human β1-adrenergic receptor via threading-based homology modeling for implications in structure-based drug designingCompound activity prediction using models of binding pockets or ligand properties in 3D.Comparison of dynamics of extracellular accesses to the β(1) and β(2) adrenoceptors binding sites uncovers the potential of kinetic basis of antagonist selectivity.Structure-function of the G protein-coupled receptor superfamily.Leu128(3.43) (l128) and Val247(6.40) (V247) of CXCR1 are critical amino acid residues for g protein coupling and receptor activation.Allosteric sodium in class A GPCR signalingLigand-dependent conformations and dynamics of the serotonin 5-HT(2A) receptor determine its activation and membrane-driven oligomerization propertiesComparative analysis of the heptahelical transmembrane bundles of G protein-coupled receptors.Action of molecular switches in GPCRs--theoretical and experimental studies.Full and partial agonists of thromboxane prostanoid receptor unveil fine tuning of receptor superactive conformation and G protein activation.Residues remote from the binding pocket control the antagonist selectivity towards the corticotropin-releasing factor receptor-1.Structural features of β2 adrenergic receptor: crystal structures and beyond.Characterization of G protein coupling mediated by the conserved D134(3.49) of DRY motif, M241(6.34), and F251(6.44) residues on human CXCR1.Structural Insights into the Dynamic Process of β2-Adrenergic Receptor SignalingComparative MD Simulations Indicate a Dual Role for Arg1323.50 in Dopamine-Dependent D2R Activation.Pharmacological Analysis and Structure Determination of 7-Methylcyanopindolol-Bound β1-Adrenergic Receptor.Induction of cardiac fibrosis by β-blocker in G protein-independent and G protein-coupled receptor kinase 5/β-arrestin2-dependent Signaling pathways.Structural features embedded in G protein-coupled receptor co-crystal structures are key to their success in virtual screening.Advances in receptor conformation research: the quest for functionally selective conformations focusing on the β2-adrenoceptorHow Can Mutations Thermostabilize G-Protein-Coupled Receptors?Synthesis and structure-affinity relationships of selective high-affinity 5-HT(4) receptor antagonists: application to the design of new potential single photon emission computed tomography tracers.Molecular Determinants of CGS21680 Binding to the Human Adenosine A2A ReceptorMolecular basis for dramatic changes in cannabinoid CB1 G protein-coupled receptor activation upon single and double point mutations.Allosteric nanobodies reveal the dynamic range and diverse mechanisms of G-protein-coupled receptor activationThe role of ligands on the equilibria between functional states of a G protein-coupled receptor.Lifting the lid on GPCRs: the role of extracellular loops.The importance of interactions with helix 5 in determining the efficacy of β-adrenoceptor ligands.X-ray structural information of GPCRs in drug design: what are the limitations and where do we go?Molecular modeling of vasopressin receptor and in silico screening of V1b receptor antagonists.Structural determinants of arrestin functionsStructure-based and fragment-based GPCR drug discovery.
P2860
Q26852976-45342A17-4BCB-43A0-B181-FB998DF4A716Q26866010-F4BDBF5F-D978-4744-82D1-D167E184822EQ26991761-DC6728F2-4318-4139-A484-370126D8B054Q27009220-846765C5-E787-41EF-BE1F-2355133F9B77Q27676608-65803C1D-2CE9-4ADA-AC4B-EAA81D99E6B1Q27676919-195AAB94-E3B5-487E-A342-C41B597CE412Q27679036-AE66750A-816A-449C-ABF2-0CDFA9D2E630Q27682443-BCD242D7-D04D-434B-80FD-68B87EC3DE4CQ28480422-38F4B137-C6F5-4FFF-B189-073E3ED40B74Q28546076-19F3A006-0EC9-4F89-B9E7-DE3AE420CCC7Q30423071-8AA14A50-ABF6-4D97-95C8-0E283ACF6F18Q30521288-21E430AB-B3D2-4AD5-8D83-C2829516AC5FQ30576993-658E7C01-7E1F-4422-9144-C59CEF573345Q31088115-972931E5-881D-4C6E-BA77-7D31421F1989Q33931569-1225DB6D-793C-4ADD-9704-55CF10A6477AQ34244869-C4417EB6-6C89-40D2-9B81-942C953D352AQ34251242-FB6ED722-1923-48DA-98A4-1E0D93ED89C1Q34251407-B68E8C28-C214-4041-9C71-A383810DB341Q34653979-8F61BE46-38BA-4401-9353-FEEB0B83589EQ35020584-17C20CF0-B9D7-4518-AD5C-79D5EF3DF72CQ35093808-2DB3056E-9E13-40F2-B0AF-ABB43C8DA99CQ35214469-D29C6408-A25D-47F8-A50D-304BCFC9632EQ35638953-4DDE0CC9-60DF-4905-8507-5FCA10B5010CQ35887927-C69C4C5A-91AC-4859-B5F9-255111D5B5BDQ36316813-EB97BEB6-E258-4E3F-873B-C0185DFBD6F9Q36318886-7999AC76-FF19-43C8-8F03-B66062DC6E25Q36336103-EFA57498-60A0-4263-8CD2-08326327D65FQ36342155-CF349879-0C49-4045-ABC0-41AB41AACE1AQ36421791-7D6D3E7A-1758-4E0E-B534-5847AB009033Q36431626-73B1E801-CDD8-47CA-82C9-D31B32D9A470Q36482631-949C29CB-F639-4029-9F56-52F16CEC54FFQ36619992-692F2ED8-2E90-492F-A6AD-A85EAEBB575EQ37127495-4CC0B18C-B38D-46C3-BB15-73166C8B047EQ37149545-8E4DBF4D-5253-41F0-B7CD-5479E7716A66Q37921853-EEB10915-C79B-4080-A778-1AADBC468419Q38077224-1B8C786A-C304-4CFC-ABF2-B0539CDDC9F8Q38093833-21AD53D5-F191-4995-B552-09E0BA1A6559Q38107508-549EE83D-E404-4B98-A9E8-9CE0B6FAAD41Q38114211-FFBDC72F-9817-44A3-903B-71A1AF0B536FQ38172457-2AD8057A-23D5-4B04-BACE-A24F9CE9227B
P2860
Two distinct conformations of helix 6 observed in antagonist-bound structures of a 1-adrenergic receptor
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Two distinct conformations of ...... es of a 1-adrenergic receptor
@ast
Two distinct conformations of ...... es of a 1-adrenergic receptor
@en
Two distinct conformations of ...... es of a 1-adrenergic receptor
@nl
type
label
Two distinct conformations of ...... es of a 1-adrenergic receptor
@ast
Two distinct conformations of ...... es of a 1-adrenergic receptor
@en
Two distinct conformations of ...... es of a 1-adrenergic receptor
@nl
prefLabel
Two distinct conformations of ...... es of a 1-adrenergic receptor
@ast
Two distinct conformations of ...... es of a 1-adrenergic receptor
@en
Two distinct conformations of ...... es of a 1-adrenergic receptor
@nl
P2093
P2860
P50
P3181
P356
P1476
Two distinct conformations of ...... of a beta1-adrenergic receptor
@en
P2093
Andrew G W Leslie
Maria J Serrano-Vega
Patricia C Edwards
Rouslan Moukhametzianov
P2860
P304
P3181
P356
10.1073/PNAS.1100185108
P407
P577
2011-05-03T00:00:00Z